Showing results (181-190 of 335) with videos related to

Sort By:
Pageof 34
Chemotherapy|January 9, 2013
Risk factors for predicting severe neutropenia induced by amrubicin in patients with advanced lung cancerHiroyuki Watanabe, Hiroaki Ikesue, Marina Oshiro, et al.
Cancer Science|February 8, 2013
Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitorsKazuto Furuyama, Taishi Harada, Eiji Iwama, et al.
The Oncologist|December 23, 2018
A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung CancerAkihiro Yoshimura, Yusuke Chihara, Koji Date, et al.
Cancer Research|March 31, 2012
Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinomaShohei Miyamoto, Hiroyuki Inoue, Takafumi Nakamura, et al.
Cancer Science|February 28, 2020
A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patientsIkuo Sekine, Yasushi Shintani, Takehito Shukuya, et al.
The Journal of Gene Medicine|October 9, 2003
Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion moleculeYosef S Haviv, Koichi Takayama, Peter A Nagi, et al.
Thoracic Cancer|April 23, 2025
Chest Tube Drainage, Bone Radiotherapy, and Brain Radiotherapy in Advanced Lung Cancer: A Retrospective Analysis of Associated Factors and SurvivalShoko Sonobe Shimamura, Takehito Shukuya, Kazuhisa Takahashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2015
Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung CancerKeiichi Ota, Koichi Azuma, Akihiko Kawahara, et al.
Nagoya Journal of Medical Science|August 15, 2022
＜Editors' Choice＞ Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experienceGen Suzuki, Hideya Yamazaki, Norihiro Aibe, et al.
Biological & Pharmaceutical Bulletin|August 4, 2015
Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung CancerHiroaki Ikesue, Hiroyuki Watanabe, Megumi Hirano, et al.
Pageof 34